SOURCE: Gilead Sciences

DESCRIPTION:

As COVID-19 began to spread around the world, Gilead employees worked around the clock to advance the company’s investigational antiviral.

In the next episode of our “Possible” series, meet Laura Bauer, a scientist in the company’s Formulation and Process Development group. Learn how she worked with her team, colleagues at Gilead, and partners across a wide manufacturing and supply chain network to expand production.

Watch other episodes of our “Possible” series here.

Tweet me: As COVID-19 began to spread around the world, @GileadSciences employees worked around the clock to advance the company’s investigational antiviral. https://bit.ly/3gdU1GD

KEYWORDS: NYSE: GILD, Gilead, COVID-19, antiviral